Huang Wei, Whittaker Kelly, Zhang Huihua, Wu Jian, Zhu Si-Wei, Huang Ruo-Pan
1 Raybiotech, Inc. , Guangzhou, China .
2 RayBiotech, Inc. , Norcross, Georgia .
Assay Drug Dev Technol. 2018 Feb/Mar;16(2):74-95. doi: 10.1089/adt.2017.808. Epub 2018 Feb 2.
Antibody arrays represent a high-throughput technique that enables the parallel detection of multiple proteins with minimal sample volume requirements. In recent years, antibody arrays have been widely used to identify new biomarkers for disease diagnosis or prognosis. Moreover, many academic research laboratories and commercial biotechnology companies are starting to apply antibody arrays in the field of drug discovery. In this review, some technical aspects of antibody array development and the various platforms currently available will be addressed; however, the main focus will be on the discussion of antibody array technologies and their applications in drug discovery. Aspects of the drug discovery process, including target identification, mechanisms of drug resistance, molecular mechanisms of drug action, drug side effects, and the application in clinical trials and in managing patient care, which have been investigated using antibody arrays in recent literature will be examined and the relevance of this technology in progressing this process will be discussed. Protein profiling with antibody array technology, in addition to other applications, has emerged as a successful, novel approach for drug discovery because of the well-known importance of proteins in cell events and disease development.
抗体阵列是一种高通量技术,能够以最少的样本量需求对多种蛋白质进行平行检测。近年来,抗体阵列已被广泛用于识别疾病诊断或预后的新生物标志物。此外,许多学术研究实验室和商业生物技术公司开始在药物发现领域应用抗体阵列。在本综述中,将探讨抗体阵列开发的一些技术方面以及目前可用的各种平台;然而,主要重点将是讨论抗体阵列技术及其在药物发现中的应用。将研究药物发现过程的各个方面,包括靶点识别、耐药机制、药物作用的分子机制、药物副作用以及在临床试验和患者护理管理中的应用,这些方面在最近的文献中已使用抗体阵列进行了研究,并将讨论该技术在推进这一过程中的相关性。除其他应用外,由于蛋白质在细胞事件和疾病发展中的重要性众所周知,利用抗体阵列技术进行蛋白质谱分析已成为一种成功的新型药物发现方法。